Hikma says all options are on the table for its beleaguered generics business, with an immediate sale unlikely but the door open for a longer-term exit strategy. Meanwhile, the firm has also offered an update on recruitment for a new CEO.
In candid comments made during the J.P. Morgan Healthcare Conference, Hikma has acknowledged that it could be considering an exit strategy for its US generics business after a tough year that has seen forecasts slashed amid heavy pricing and competitive pressures.
Last year, the firm made multiple cuts to its generics guidance as first-half sales dropped by 18%, with the firm’s...
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
Steffen Wagner has taken over as Stada’s head of Germany, adding to his existing responsibilities in Europe, after Eelco Ockers stepped down from the role. Ockers’ departure comes as German generics giant Stada restructures its business to bring its branded and consumer health interests into closer alignment as part of a more streamlined model.
Video provides a powerful way to help you prove your point. When you click Online Video, you can paste in the embed code for the video you want to add. You can also type a keyword to search online for the video that best fits your document.
